“Nothing for something” doesn’t sound like much of a deal. But when that “nothing” is zero tariffs on UK pharmaceutical products being sold in the US, then that’s something to shout about – in today’s world anyway. Topline details of the UK-US pharma deal were briefed earlier this week. In return for zero tariffs, the […]
Biocomposites announced expanded approval in India for STIMULAN® Rapid Cure to be mixed with antimicrobials to treat infection Biocomposites announces the expanded approval for STIMULAN® Rapid Cure in India. The approval from India’s Central Drugs Standard Control Organisation (CDSCO) allows STIMULAN® Rapid Cure to be mixed with a wider variety of antibiotics than before, including in combination, […]
People in Europe and the US rarely pay for prescription drugs out of their own pockets. In Europe, their national health services almost always pick up the tab – even if some people have to contribute by way of a prescription charge. In the US, the health insurer normally foots the bill. But things have […]
What an incredible few days at Jefferies & London Life Science Week! 🎉 A huge thank you to Jefferies, the BioIndustry Association (BIA), MedCity, and London & Partners for hosting this goliath event. It gets bigger, better and more impactful every year, and we’re proud to be part of it. We are glad so many […]
You have probably already seen the news: not one but two major European life science funds have closed in the last week – collectively raising a massive €1.15 billion! Last Friday (November 14), leading European life sciences venture capital firm Medicxi announced it had closed its €500 million Medicxi V fund. And on Monday, (November […]
